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Objectives This study was designed to evaluate whether the absence of coronary calcium could rule out 50% coronary
stenosis or the need for revascularization.
Background The latest American Heart Association guidelines suggest that a calcium score (CS) of zero might exclude the
need for coronary angiography among symptomatic patients.
Methods A substudy was made of the CORE64 (Coronary Evaluation Using Multi-Detector Spiral Computed Tomography
Angiography Using 64 Detectors) multicenter trial comparing the diagnostic performance of 64-detector com-
puted tomography to conventional angiography. Patients clinically referred for conventional angiography were
asked to undergo a CS scan up to 30 days before.
Results In all, 291 patients were included, of whom 214 (73%) were male, and the mean age was 59.3  10.0 years. A
total of 14 (5%) patients had low, 218 (75%) had intermediate, and 59 (20%) had high pre-test probability of
obstructive coronary artery disease. The overall prevalence of 50% stenosis was 56%. A total of 72 patients
had CS  0, among whom 14 (19%) had at least 1 50% stenosis. The overall sensitivity for CS  0 to predict
the absence of 50% stenosis was 45%, specificity was 91%, negative predictive value was 68%, and positive
predictive value was 81%. Additionally, revascularization was performed in 9 (12.5%) CS  0 patients within 30
days of the CS. From a total of 383 vessels without any coronary calcification, 47 (12%) presented with 50%
stenosis; and from a total of 64 totally occluded vessels, 13 (20%) had no calcium.
Conclusions The absence of coronary calcification does not exclude obstructive stenosis or the need for revascularization
among patients with high enough suspicion of coronary artery disease to be referred for coronary angiography,
in contrast with the published recommendations. Total coronary occlusion frequently occurs in the absence of
any detectable calcification. (Coronary Evaluation Using Multi-Detector Spiral Computed Tomography Angiogra-
phy Using 64 Detectors [CORE-64]; NCT00738218) (J Am Coll Cardiol 2010;55:627–34) © 2010 by the
American College of Cardiology Foundation
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Zero Coronary Calcium and Obstructive Stenosis February 16, 2010:627–34Coronary artery calcification is
highly specific for atherosclerosis
(1,2) and is thought to be origi-
nated as part of the healing
mechanism of usually subclinical
plaque rupture events (1,3). None-
theless, calcification is only 1 of the
components of atherosclerotic
plaques and develops late in the
atherosclerotic process. Because
ruptured culprit plaques are not
necessarily calcified (1,4), it is
widely assumed that coronary cal-
cification predicts events based on
the overall atherosclerosis burden
rather than the detection of vul-
nerable plaques per se (5). Thus,
it is intuitive to hypothesize
that patients without any coro-
nary calcification might present
with symptoms caused by sig-
nificant stenosis.
Coronary calcium scans used
o determine calcium score (CS) entail relatively low risks;
See page 635
he radiation exposure is limited to 1.0 to 2.0 mSv, and the
est does not utilize iodinated contrast. The main intrinsic
imitations of both conventional coronary angiography
CCA) and multidetector computed tomography (MDCT)
ngiography in terms of patient safety include the use of
oentgenograms (6) as well as the need for iodinated
ontrast agents with their associated risk of adverse reactions
7). The greater the radiation dose, the greater the risk of
eterministic and stochastic injury (6). Additionally, me-
hanical complications of CCA, although infrequent, can be
erious. The definition of a CS threshold below which
ignificant obstructive CAD could be virtually excluded
ould potentially serve as a gatekeeper to coronary angiog-
aphy. Importantly, the American College of Cardiology
ACC) together with the American Heart Association
AHA) have issued an Expert Consensus Document that
tates: “For the symptomatic patient, exclusion of measur-
ble coronary calcium may be an effective filter before
ndertaking invasive diagnostic procedures or hospital ad-
ission. Scores 100 are typically associated with a low
robability (2%) of abnormal perfusion on nuclear stress
ests, and3% probability of significant obstruction (50%
tenosis) on cardiac catheterization” (5).
Our aims were to evaluate the prevalence of obstructive
nd nonobstructive CAD in a multicenter international trial
nvolving patients with suspected CAD and CS  0
linically referred for CCA, as well as to evaluate the rate of
Abbreviations
and Acronyms
AHA  American Heart
Association
AUC  area under the
receiver-operating
characteristic curve
CAD  coronary artery
disease
CCA  conventional
coronary angiography
CI  confidence interval
CS  calcium score
ECG  electrocardiogram
ED  emergency
department
MDCT  multidetector
computed tomography
OR  odds ratio
QCA  quantitative
coronary angiographylinically driven revascularization in those patients. Addi- wionally, we sought to further investigate the in vivo rela-
ionship between the absence of coronary calcification and
essel total occlusion.
ethods
he CORE64 (Coronary Evaluation Using Multi-Detector
piral Computed Tomography Angiography Using 64 De-
ectors) trial (8) was designed to prospectively include
atients 40 years of age with suspected CAD and planned
linically-indicated CCA within 30 days to compare the
CA with new-generation 64-detector MDCT angiogra-
hy. The complete protocol and methods of the CORE64
rial are described elsewhere (9). Briefly, patients were
ecruited from 9 centers around the world (3 in the U.S.,
nd 1 each in Brazil, Germany, Japan, Singapore, Canada,
nd the Netherlands). Institutional review boards from all of
he participating centers approved the study protocol, and
ll patients signed the same informed consent form. All
ocal protocols were approved by a central institutional
eview board at Johns Hopkins Hospital.
Exclusion criteria included known allergy to iodinated
ontrast media or history of contrast-induced nephropathy,
istory of multiple myeloma or previous organ transplanta-
ion, calculated creatinine clearance of 60 ml/min, atrial
brillation or uncontrolled tachyarrhythmia, second- or
hird-degree atrioventricular block, evidence of New York
eart Association functional class III or IV heart failure,
nown or suspected moderate or severe aortic stenosis,
revious coronary cardiac surgery, coronary artery interven-
ion within the last 6 months, known or suspected intoler-
nce to beta-blockers, body mass index 40 kg/m2, and
regnancy. While there were no restrictions to enrollment
ased on coronary CS to avoid selection bias, as a pre-
pecified criterion, only patients with Agatston CS 600
ere included in the primary analysis; patients with CS
600 were scanned and included in a separate registry. The
DCT raw image as well as CCA digital datasets were
ransferred for reconstruction and interpretation at distinct
ore laboratories, where analysis was performed in com-
letely blinded fashion relative to clinical data and cross-
odality results.
DCT acquisition protocol and data analysis. All pa-
ients were scanned by similar commercially-available 64-
etector MDCT scanners (Aquilion, Toshiba Medical Sys-
ems, Tochigi, Japan). The CS scans were obtained using
tandard techniques with slice collimation 4  3.0 mm,
00 mA, 120 kV, and gantry rotation time 0.4 s (5).
ffline analyses in remote workstations with dedicated
ardiac analysis software (Vitrea2 version 3.0.9.1, Vital
mages, Minnetonka, Minnesota) were used to calculate
gatston CS.
CA data acquisition and analysis. Coronary angiogra-
hy was performed using standard angiographic techniques
ithin 30 days from the CS study and was clinically driven.
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February 16, 2010:627–34 Zero Coronary Calcium and Obstructive Stenosisoronary angiographic images were saved in DICOM
ormat and forwarded to the CCA core laboratory.
The coronary tree was divided into 19 segments on the
asis of a combination of the CASS (Coronary Artery
urgery Study) and AHA segmentation standards (5). All
oronary segments 1.5 mm in diameter were visually
nalyzed, and in every 30% stenosis, quantitative coronary
ngiography (QCA) was performed using edge-detection
echniques (CAAS II QCA Research Version 2.0.1, PIE
edical Imaging, Maastricht, the Netherlands). Segments
hat could not be accurately visualized because of reduced
mage quality or inadequate contrast filling were deemed
nevaluable. The most significant stenosis was noted for
ach vessel and patient. Significant stenosis by CCA was
efined by luminal diameter narrowing of 50% as mea-
ured by QCA.
linical data collection and interpretation. Research co-
rdinators from each site entered clinical data into a
eb-based data management system. All patients referred
or CCA from the emergency department (ED) were
efined as ED patients; electrocardiogram (ECG), troponin
evels, and symptoms were obtained after admission and
efore CCA. Chest pain at rest was defined as the presence
f acute chest, epigastric, neck, jaw, or arm pain or discom-
ort or pressure without apparent noncardiac cause, 20
in in duration within 48 h of hospital admission. Tropo-
in results were adjusted for each specific laboratory stan-
ard. The presence of ischemic changes on the ECG (i.e.,
0.5 mV ST-segment deviation on multiple contiguous
eads) denoted a “positive ECG.” The pre-test probability of
AD was derived using the method validated by Morise et
l. (10) that uses a scoring system to define low, interme-
iate, and high pre-test probability of CAD.
tatistical analysis. Continuous data are expressed as mean
nd SD or median and interquartile ranges when appropri-
te. Proportion comparisons were performed by chi-square
ests, and differences in mean values were compared using
he Student t test. Logistic univariable and multivariable
nalyses were used for determining associations with the
resence of coronary obstructive lesions, and clustering by
atient was employed for vessel analyses. The accuracy of
ontinuous variables for the detection of obstructive CAD
as measured as the area under the receiver-operating
haracteristic curve (AUC), and the association between the
S and the maximum degree of coronary stenosis in a
atient was determined by linear regression analysis. All p
alues 0.05 were considered to indicate statistical signifi-
ance. All p values are 2-sided.
esults
f 316 eligible patients, 4 were excluded because of major
rotocol deviations, 11 were excluded because CCA was
ancelled or performed with small catheters that were
nappropriate for QCA analysis (protocol deviation), and 10
ere excluded because of MDCT technical failure or cneligibility at the time of scanning, resulting in a total of
91 patients included in the study (mean age 59.3  10.0
ears; 78 [26.8%] women) from November 2005 through
anuary 2007. Clinical demographics are summarized in
able 1.
atient-based analysis. Figure 1 provides a summary of
he patient-based results for the prevalence of coronary
tenosis and revascularization according to CS. Overall
revalence of 50% coronary stenosis by CCA was 56%,
nd for 70% stenosis it was 45%. Patients with 0 CS were
ounger than patients with 0 CS (age 55.9  9.9 years vs.
0.5  9.8 years, p  0.001) and the proportion of women
as significantly higher (40.3% vs. 22.4%, p  0.003).
Calcium score weakly correlated with the highest degree
f coronary stenosis among individual patients (R2  0.16,
 0.001), as can be seen in Figure 2, and the ability of CS
o predict the presence of significant lesions was moderate,
ith an AUC of 0.77 (95% confidence interval [CI]: 0.72 to
.83, p  0.001). The presence of any coronary calcium
CS 0) significantly increased the chance of a patient
aving 50% coronary stenosis (odds ratio [OR]: 8.1, p 
.001 after adjusting for age, sex, hypertension, dyslipide-
ia, family history of premature CAD, diabetes, race, and
ospitalization). Conversely, the absence of detectable cor-
nary calcium (CS  0) significantly increased the likeli-
ood of a patient being free of 50% coronary stenosis
OR: 8.8, p  0.001 after adjusting for the same variables).
Nonetheless, among 72 patients with 0 CS, 14 (19%,
5% CI: 10% to 28%) had at least 1 50% (mean age
3.8  9.5 years; age range 41 to 76 years) and 11 (15%,
5% CI: 7% to 23%) had at least 1 70% stenosis by CCA,
s shown in Figure 3. The overall sensitivity for CS  0 to
redict the absence of 50% lesions by CCA on individual
articipants was 45%, specificity was 91%, negative predic-
ive value was 68%, and positive predictive value was 81%.
igure 4 demonstrates an example of a CS  0 outpatient
ho presented with a severe (70%) stenosis in the left
escending coronary artery. The only variable significantly
ssociated with the presence of obstructive CAD in CS  0
atients was ED presentation, found in both univariable and
ultivariable analyses after accounting for the risk factors
isted in Table 2.
In all, 100 patients were revascularized within 30 days of
he CCA procedure, 88 percutaneously and 12 surgically.
evascularization was performed in 9 (13%, 95% CI: 4% to
0%) of the 72 patients with CS  0, 6 (25%, 95% CI: 8%
o 42%) of the 24 patients with CS  1 to 10, and 85 (44%,
5% CI: 36% to 50%) of the 195 patients with CS 10
p  0.001 for the trend), as shown in Figure 3. Among
he 9 patients with CS  0 who were revascularized, 4
ere referred from outpatient clinics and 5 were referred
rom the ED.
Of the 42 patients who presented to the ED with
egative ECG and troponin tests, 8 had CS  0, of whom
(38%) presented with obstructive CAD on CCA. This isontrasted with a lower prevalence (8 [14%] patients of 56
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Zero Coronary Calcium and Obstructive Stenosis February 16, 2010:627–34ith CS 0, p 0.117 for the proportion between ED and
mbulatory patients) of obstructive CAD among those who
resented as outpatients with 0 CS.
A total of 14 (5%, 95% CI: 2% to 7%) patients had low
median CS  0; range 0 to 540), 218 (75%, 95% CI: 69%
Baseline CharacteristicsTable 1 Baseline Characteristics
0
(n  72
Age, yrs 55.9 9.9
Men 43 (60)
Race
White 41 (57)
Black 11 (15)
Asian 16 (22)
Other 4 (6)
BMI, kg/m2* 27 4.
Hypertension 43 (60)
Diabetes mellitus 12 (17)
Dyslipidemia 35 (49)
Smoking
Current 15 (21)
Past 22 (31)
Never 35 (49)
Family history of CAD 16 (22)
Chest pain (within 30 days) 38 (53)
ED presentation† 16 (22)
Presence of any 50% stenosis‡ 14 (19)
Disease distribution by CCA‡
No disease 56 (78)
Single-vessel disease 14 (19)
2-vessel disease 2 (3)
3-vessel disease 0
Revascularization in 30 days 9 (13)
Values are mean  SD or n (%). *Calculated as weight in kilograms d
the emergency department (ED). ‡Defined by quantitative convention
BMI  body mass index; CAD  coronary artery disease.
Figure 1 Distribution of Patients on the Basis of CS and Coron
CS  calcium score; pts  patients.o 79%) had intermediate (median CS  63; range 0 to
79), and 59 (20%, 95% CI: 15% to 25%) had high (median
S  118; range 0 to 567) pre-test probability of obstruc-
ive CAD (9). For each point increment in the Morise
core, a 15% increase in the probability of a significant
Calcium Score
1–10
(n  24)
>10
(n  195) p Value
60.1 9.5 60.5 9.9 0.003
16 (67) 154 (79) 0.005
0.014
18 (75) 137 (70)
1 (4) 6 (3)
5 (21) 45 (23)
0 7 (4)
28 4.7 28 4.3 0.55
16 (67) 133 (68) 0.43
3 (13) 53 (27) 0.083
14 (58) 126 (65) 0.059
0.048
3 (13) 38 (19)
7 (29) 90 (46)
14 (58) 67 (34)
4 (17) 74 (25) 0.39
11 (48) 120 (62) 0.25
12 (50) 61 (31) 0.035
11 (46) 138 (71) 0.001
0.001
11 (46) 53 (27)
10 (42) 49 (25)
3 (13) 61 (31)
0 32 (16)
6 (25) 85 (44) 0.001
y height in meters squared. †Patients referred for angiography from
ary angiography (CCA).
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February 16, 2010:627–34 Zero Coronary Calcium and Obstructive Stenosistenosis by CCA was observed (p  0.003, 95% CI: 1.05 to
.26). Among patients with 0 CS, none of the 8 patients
ith low CAD probability, 12 (21%) of 57 patients with
ntermediate probability, and 2 (29%) of the 7 patients with
igh probability had at least 1 significant stenosis on CCA
p  0.001 for the trend).
Importantly, low CAD probability alone did not rule out
ignificant stenosis, as 4 (29%, 95% CI: 5% to 52%) of 14
atients had obstructive CAD, as compared with 122 (56%,
5% CI: 48% to 62%) of 218 patients with intermediate
robability and 37 (63%, 95% CI: 50% to 74%) of 59
atients with high probability. In fact, although the Morise
core was associated with obstructive CAD in univariable
nalysis (OR: 1.15, 95% CI: 1.05 to 1.26, p  0.003), it did
Figure 2 Individual Values of CS and Maximum Coronary Steno
Linear regression plot showing the poor correlation between the maximum degree
stenosis by conventional coronary angiogram (CCA) and the calcium score (CS)
Figure 3
Prevalence of Obstructive CAD and Need
for Clinically Indicated Revascularization
Among Patients in Different CS Categories
As the CS increases, the prevalence of obstructive coronary artery disease
(CAD) and revascularization also increase (p  0.001 for all trends). Note that
the group of 0 CS patients has high prevalence of obstructive CAD and
revascularization. The blue bars indicate CCA 50%; the red bars indicate
CCA 70%; and the green bars indicate revascularization. Abbreviations as
in Figure 2.oot reach statistical significance when adjusted to CS (OR:
.09, 95% CI: 0.99 to 1.20), the latter of which was
ignificantly associated in both univariable analysis (OR:
.006, 95% CI: 1.004 to 1.009, p  0.001) and after
djusting to the Morise score (OR: 1.006, 95% CI: 1.004 to
.008, p  0.001).
essel-based analysis. Of the 873 vessels analyzed, 271
31%) and 189 (22%) had at least 1 50% or 70%
oronary stenosis by CCA, respectively. The absence of
oronary calcification did not exclude the presence of
bstructive CAD, because 47 (12%, 95% CI: 9% to 15%) of
he 383 coronaries without any calcification had at least 1
50% lesion (28 of them presented as outpatients). Accord-
ngly, the ability of vessel CS to predict 50% lesions was
nly moderate, with an AUC curve of 0.75 (95% CI: 0.72 to
.78, p  0.001). Importantly, in this regard, of 64 vessels
ith complete obstructions, 13 (20%, 95% CI: 10% to
0%) had no calcium.
iscussion
S as a gatekeeper to angiography. Because CS scans are
ast, offer low radiation dose, and predict cardiovascular
vents over and above conventional risk factors for CAD
5,11,12), they are frequently performed before MDCT
ngiography in the clinical setting. The main objective of
his study was to evaluate the ability of a negative CS scan
o rule out significant (50%) coronary stenosis, thus
ssessing the value of a calcium scan as a gatekeeper for
ngiographic studies in symptomatic patients with sus-
ected CAD. This would prevent iodinated contrast and
ncreased ionizing radiation exposures, prevent the risk of
nvasive angiography, and reduce cost and patient anxiety. A
ignificant strength of our study was the prospective nature
nd the thorough analysis of the CCAs and CS scans in
linded, centralized core laboratories. Additionally, the use
Subjects
onary
atient.sis in
of cor
in a pf QCA as the method for stenosis assessment made the
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Zero Coronary Calcium and Obstructive Stenosis February 16, 2010:627–34CA results more robust, given the known overestimation
f stenosis severity by visual assessment (13,14).
As expected, we found a positive association between
oronary calcium and stenosis, as demonstrated by the linear
orrelation of the maximum degree of stenosis and the total
S per patient, as well as the strong and independent
ssociation between any coronary calcium and the presence
f 50% stenoses. This is in agreement with perfusion
cintigraphic studies that demonstrated that as the CS
ncreases, so does the prevalence and severity of myocardial
erfusion abnormalities (15). Nonetheless, our results dem-
nstrate that in patients with clinical indication for CCA, a
S  0 cannot be used as a gatekeeper, because 19% of
hese patients had obstructive CAD. The sensitivity and
egative predictive value for a CS 0 to predict the absence of
50% lesions on CCA were low (45% and 68%, respectively).
Figure 4 A Patient From Our Study
Example of an outpatient 53-year-old man with 0 calcium score and severe stenosis
on the midportion of the left descending coronary (arrows), as can be seen on the
conventional angiogram (A), on the multiplanar reformatted image (B), and on the
3-dimensional volume rendered image (C) from coronary computed tomography angio-
gram. The stenosis also extends to a diagonal branch, as can be seen in A and C.mportantly, that 12.5% of patients with CS  0 were ievascularized attests to the clinical significance of such
esions. Although coronary calcification is in general asso-
iated with obstructive stenosis and the absence of calcifi-
ation is correlated with the absence of stenosis, our results
ndicate that CS cannot be used to safely exclude the
resence of obstructive CAD. Emergency department ad-
ission was the only variable associated with CS  0 and
bstructive CAD, highlighting that calcium scans are espe-
ially not reliable in this setting.
These results are in resonance with previous single-center
tudies documenting a 24% prevalence of obstructive CAD
n patients with 0 CS referred to CCA (16). In another
tudy, 7% of chest pain patients with CS  0 had obstruc-
ive CAD (17), whereas in a third study, the authors found
16% incidence of coronary plaque in CS 0 patients (18).
imilarly, another, more recent single-center study found
hat 20% of the patients with CS  0 presenting to the ED
ad at least 1 obstructive coronary lesion (19). Conversely, a
revious single-center study reported discordant results. In
hat study, the authors found that CS  0 patients had
1% prevalence of obstructive CAD by CCA (20). Inter-
stingly, in addition to differences in clinical presentation,
he above discrepancies may reflect known racial or ethnic
ifferences in calcification patterns (12), which may also play
n important role in the limited ability of CS to exclude
ignificant stenosis.
The present data are particularly important in light of the
urrent Expert Consensus Document endorsed by the ACC
nd the AHA (5). Based on our findings, this strategy
ould lead to a high percentage of patients with a missed
iagnosis of obstructive CAD in a group of patients with
igh enough clinical suspicion for CAD to assure an
ndication for invasive coronary angiography. This strategy
ould potentially be applicable to patients with a calculated
ow pre-test probability of CAD and no coronary calcium,
ecause none of these patients had obstructive CAD in our
tudy, although the limited number of such patients (only 8
ad no calcium and low pre-test probability of CAD)
arrants further investigation before definitive conclusions
an be drawn.
iological considerations. Although highly specific for
therosclerosis, coronary calcification has been shown to
evelop late in the atherosclerotic process. One of the most
ccepted classifications of the progression of atherosclerosis
ndorsed by the AHA and published by Stary et al. (1)
roposes an usual pattern of disease progression, in which
oronary calcification appears on type V lesions (fibroathe-
oma) downstream from type IV lesions (formed atheroma).
mportantly, the authors recognize that type IV lesions can
lready rupture and become unstable, leading to acute
oronary events (1). This finding is in agreement with
esults from ex vivo studies documenting that atheroscle-
otic lesions develop in 5 steps, namely, phase 1, early; phase
, advanced; phases 3 and 4, acute complicated thrombosed
laques (symptomatic or not, stenotic or not); and phase 5,
n which the lesion calcifies, as part of the rupture-healing
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therosclerosis can occur in the absence of CT-detectable
alcification. Moreover, 20% of the totally occluded vessels had
o calcium, emphasizing that calcification is not required for
oronary occlusion, often associated with plaque rupture and
cute coronary events.
resence of atherosclerosis and risk for coronary events.
t should be emphasized, however, that CS is usually
easured in asymptomatic patients with intermediate risk
or events, and it has been consistently shown that a CS 
in this patient group confers a low risk of coronary events
n 5 to 10 years (5,12). Our patient group of those with
uspected CAD is at much higher risk, because they
epresent patients referred for CCA. In this setting, our
esults indicate that the absence of coronary calcification
ight not be as protective, because obstructive CAD also
as prognostic value. The extent, location, and severity of
oronary obstructive lesions are important predictors of
utcome and identify subgroups of patients likely to benefit
rom revascularization (22–24). Importantly, more recent
tudies have shown that stenosis severity as assessed by
DCT angiography may also independently predict events
nd total mortality (25–28).
tudy limitations. It should be noted that there is an
mportant limitation of the present study: we did not
valuate the prognostic importance of obstructive CAD in
atients with CS  0. This evaluation would be important,
lthough indirect evidence supports the location and sever-
ty of coronary stenosis as a prognostic marker.
onclusions
he present study demonstrates that although coronary
alcification is associated with significant stenosis, the ab-
ence of coronary calcification does not exclude obstructive
AD or the need for clinically indicated coronary revascu-
arization both in the outpatient department as well as in the
D among patients with a high enough suspicion of CAD
rompting an indication for CCA. The absence of coronary
alcification should not be used as a gatekeeper and should
Univariable (Crude) and Multivariable (AdjustedFacto s That May Be Associated With PresenceP tients Wi h 0 Coro ary Calcium Score (n  7
Table 2
Univariable (Crude) and Multivariab
Factors That May Be Associated W
Patients With 0 Coronary Calcium S
Crude
OR 95% CI
Age 0.97 0.91–1.03
Male 1.27 0.38–4.26
Race 0.85 0.45–1.59
Diabetes mellitus 1.48 0.34–6.40
Family history of CAD 2.37 0.66–8.50
Dyslipidemia 1.07 0.33–3.44
Hypertension 1.27 0.38–4.27
ED presentation 3.60 1.02–12.68
CI  confidence interval; OR  odds ratio; other abbreviations as in Tot prevent a symptomatic patient from undergoing angiog-aphy. Furthermore, a large percentage of totally occluded
essels had no evidence of calcium by CT, emphasizing that
alcification is not indispensable for plaque rupture and
cute coronary events.
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